[go: up one dir, main page]

FI890459A0 - Proteolytisk enzym specifik foer humant immunbristvirus och foerfarande foer dess syntetisering och renaturering. - Google Patents

Proteolytisk enzym specifik foer humant immunbristvirus och foerfarande foer dess syntetisering och renaturering.

Info

Publication number
FI890459A0
FI890459A0 FI890459A FI890459A FI890459A0 FI 890459 A0 FI890459 A0 FI 890459A0 FI 890459 A FI890459 A FI 890459A FI 890459 A FI890459 A FI 890459A FI 890459 A0 FI890459 A0 FI 890459A0
Authority
FI
Finland
Prior art keywords
och
foer
hiv
syntetisering
renaturering
Prior art date
Application number
FI890459A
Other languages
English (en)
Other versions
FI890459A (fi
Inventor
Stephan Oroszlan
Terry Duane Copeland
Original Assignee
Bionetics Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionetics Research Inc filed Critical Bionetics Research Inc
Publication of FI890459A publication Critical patent/FI890459A/fi
Publication of FI890459A0 publication Critical patent/FI890459A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI890459A 1987-06-01 1989-01-31 Proteolytisk enzym specifik foer humant immunbristvirus och foerfarande foer dess syntetisering och renaturering. FI890459A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/057,183 US5252477A (en) 1987-06-01 1987-06-01 Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation
PCT/US1988/001849 WO1988009815A1 (en) 1987-06-01 1988-06-01 Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation

Publications (2)

Publication Number Publication Date
FI890459A FI890459A (fi) 1989-01-31
FI890459A0 true FI890459A0 (fi) 1989-01-31

Family

ID=22009015

Family Applications (1)

Application Number Title Priority Date Filing Date
FI890459A FI890459A0 (fi) 1987-06-01 1989-01-31 Proteolytisk enzym specifik foer humant immunbristvirus och foerfarande foer dess syntetisering och renaturering.

Country Status (10)

Country Link
US (2) US5252477A (fi)
EP (1) EP0316429B1 (fi)
JP (1) JPH02500408A (fi)
KR (1) KR890701738A (fi)
AT (1) ATE105859T1 (fi)
AU (1) AU630590B2 (fi)
DE (1) DE3889625T2 (fi)
DK (1) DK41289A (fi)
FI (1) FI890459A0 (fi)
WO (1) WO1988009815A1 (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252477A (en) * 1987-06-01 1993-10-12 The United States Of America As Represented By The United States Department Of Health And Human Services Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation
US5637488A (en) * 1987-06-01 1997-06-10 The United States Of America As Represented By The Department Of Health And Human Services HIV protease gene and method for its expression
CA1340748C (en) * 1988-07-13 1999-09-14 Stephen Oroszlan Synthetic hiv protease gene and method for its expression
US5147369A (en) * 1991-07-01 1992-09-15 Wagner Michael A Forceps and method for nuclear fragment removal
US5554728A (en) * 1991-07-23 1996-09-10 Nexstar Pharmaceuticals, Inc. Lipid conjugates of therapeutic peptides and protease inhibitors
ATE253050T1 (de) 1992-03-11 2003-11-15 Narhex Ltd Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
JPH07504654A (ja) * 1992-03-11 1995-05-25 ナルヘックス リミテッド オキソ及びヒドロキシ置換炭化水素のアミン誘導体
US5872210A (en) * 1995-10-05 1999-02-16 The United States Of America As Represented By The Department Of Health And Human Services Transframe peptide inhibitor of viral protease
EP0909322B1 (en) 1996-04-30 2005-11-16 Twinstrand Therapeutics Inc. Antiviral ricin-like proteins
US6531125B1 (en) 1999-03-02 2003-03-11 Twinstrand Therapeutics Inc. Antiviral ricin-like proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252477A (en) * 1987-06-01 1993-10-12 The United States Of America As Represented By The United States Department Of Health And Human Services Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation

Also Published As

Publication number Publication date
WO1988009815A1 (en) 1988-12-15
AU630590B2 (en) 1992-11-05
EP0316429A1 (en) 1989-05-24
AU1805188A (en) 1989-01-04
FI890459A (fi) 1989-01-31
JPH02500408A (ja) 1990-02-15
DK41289D0 (da) 1989-01-30
US5252477A (en) 1993-10-12
DE3889625T2 (de) 1994-09-29
ATE105859T1 (de) 1994-06-15
DE3889625D1 (de) 1994-06-23
EP0316429A4 (en) 1991-05-22
US5354683A (en) 1994-10-11
KR890701738A (ko) 1989-12-21
EP0316429B1 (en) 1994-05-18
DK41289A (da) 1989-01-30

Similar Documents

Publication Publication Date Title
DE68912359D1 (de) Proteolytische Enzyme und ihre Verwendung in Waschmitteln.
FI890459A (fi) Proteolytisk enzym specifik foer humant immunbristvirus och foerfarande foer dess syntetisering och renaturering.
ATE102254T1 (de) Rekombinant-antikoerper.
ATE80657T1 (de) Mischungen von alpha-amylase zur verfluessigung von staerke.
DK0558630T3 (da) Retrovirale proteaseinhibitorer
AU638133B2 (en) Ribosome inactivating proteins, inactive precursor forms thereof, a process for making and a method of using
DE69229272D1 (de) Topischer fibrinogenkomplex
DE68923123D1 (de) Herstellung von Proteinen.
DK164911C (da) Inklusionskompleks mellem piroxicam og cyklodextriner og analogifremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende et saadant kompleks
FI950841A0 (fi) Retrovirusproteaasi-inhibiittoreina käyttökelpoisia N-(alkanoyyliamino-2-hydroksipropyyli)-sulfoniamideja
DK0909312T3 (da) Fremgangsmåde til fremstilling af polypeptider
NO934628L (no) Retrovirus-protease-inhibitorer
KR970009949B1 (en) Novel serine proteolytic enzyme and its process
ES8601236A1 (es) Un procedimiento para la preparacion de derivados peptidicos
DE68917099D1 (de) Produktion von sekundären aliphatischen Aminen.
KR850001149A (ko) 2-3차-부틸아미노-3'-클로로프로피오페논 말레에이트의 제조방법
ES2078072T3 (es) Inmunogeno y su utilizacion para la obtencion de anticuerpos contra hba1c.
ATE109796T1 (de) Gewebeinhibitor für metalloproteasen (timp-2).
NO174140C (no) Verktöyring, fremgangsmåte for dennes fremstilling, og et holdeverktöy for festing av et emne i verktöyringen
EP0236040A3 (en) Amino acid modified prourokinase and method of preparation
DE69309685D1 (de) Zweikomponenten-Fibrinkleber zur Verbesserung von in-Vitro Befruchtung
DE3787499D1 (de) Herstellung eines Plasminogenaktivators.
IT1239719B (it) Uso dell'anticorpo monoclonale sp-2 nella diagnostica clinica ed il monitoraggio del progredire dell'infezione hiv
ES459896A1 (es) Un metodo de preparacion de acido 6,11-dihidrodibenzo (b.e) tiepin-11-on-3-acetico.
NZ297230A (en) Thiepane compounds for detecting HIV protease

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: BIONETICS RESEARCH INC.